Proactive - Interviews for investors
hVIVO lands third challenge trial contract as market picks up sharply
hVIVO PLC has secured a third human challenge trial contract, this time with a European biotech client for an influenza study. CEO Yamin 'Mo' Khan notes a significant increase in pipeline opportunities and contract conversions, improving revenue visibility for 2026 and 2027.